Taiho Pharmaceutical Co., Ltd. is engaged in the research, development, production, distribution, and marketing of pharmaceutical products. The company develops drugs primarily in the area of oncology. It also develops other pharmaceuticals, controlled medical devices, designated quasi-drugs, second-class OTC drugs, designated second-class OTC drugs, and third-class OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; and anticancer agents for oncologists, other medical care professionals, and patients. In addition, it engages in the research and development in the areas of oncology,

Engages in priniting activities

Part of Novozymes A/S, Delta Biotechnology Ltd. is a company headquartered in Windlesham, UK, that produces and markets a range of valuable proteins from yeast using low cost manufacturing technologies. On July 06, 2006 Novozymes An acquired Delta Biotechnology Ltd.

Entrada Therapeutics’ mission is to treat devastating diseases through the intracellular delivery of biologics. Entrada’s technology enables the efficient intracellular delivery of proteins, peptides and nucleic acids, thus allowing for the development of programs across several intracellular target classes. The Company's novel approach addresses current challenges associated with both large and small molecule therapeutics and represents a fundamental advancement in the delivery of molecules into the cytosol. For more information, please visit www.entradatx.com.

Nanjing Nuoyun Biotechnology Co., Ltd., established on 2013-03-25, Business scope includes engaging in biotechnology development,technology transfer,Technical Services and Consulting;Natural sugar substitute,Natural colouring,Natural Products of Natural Preservatives,Enzyme,coenzyme biological products,Amino acids,hypolipidemic,Wholesale and import and export of cardiovascular pharmaceutical intermediates;and provide related services(Involves quota and license management,Commodities under special regulations,According to the relevant regulations of the country).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. While there are several therapies being developed with the goal of curing cancer, one of the most effective and proven approaches to this is radiation therapy (RT).

Industrial Research Limited (IRL) was a Crown Research Institute of New Zealand that was established in 1992 and merged into Callaghan Innovation, a new Crown entity, on 1 February 2013. IRL provided research, development and commercialisation services aimed at fostering industry development, economic growth and business expansion. It was established when the Department of Scientific and Industrial Research was disbanded and its staff and assets redistributed to form the research institutes in 1992.

The USC Incubator accelerates the development of USC’s top student and alumni entrepreneurs through experiential education, mentorship and community. The USC Incubator, supported by the Greif Center for Entrepreneurial Studies at USC’s Marshall School takes founders from feasibility and development work, on to customers, a tested business model, getting distribution, building a team, bootstrapping and investment preparation. They also provide access to other supporting resources, such as legal and financial assistance.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

SCM Lifescience Co., Ltd. develops drugs for stem cell therapy. It operates through following business areas: stem cell products, CMO, contract research & consulting and cosmetic. The company was founded by Sun-Wook Song in 2008 and is headquartered in Incheon, South Korea.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Korea Institute of Radiological & Medical Sciences specializes in radiation technology, research, development, genomics, and radiotherapy.

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co. Ltd. engages in the manufacture of pharmaceutical products. The firm offers injections, tablets, capsules, and granules. The company was founded on January 16, 2001 and is headquartered in Nanjing, China.